CXC Chemokines and Regulation of Granulopoiesis

CXC趋化因子和粒细胞生成的调节

基本信息

  • 批准号:
    8439395
  • 负责人:
  • 金额:
    $ 39.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-03-15 至 2018-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The chemokine receptor CXCR2 is the only receptor for ELR+ CXC chemokines in the mouse, deletion of which increases of neutrophils and progenitors in the marrow, as well as systemic expression of G-CSF and IL-17A. Our CXCL5-/- mice, which lack one ligand for CXCR2, express an intermediate phenotype, suggesting involvement of CXCL5 in controlling granulopoiesis through CXCR2. Furthermore, these mice are more resistant to severe pneumonia. Our data suggest that IL-17 regulates this phenotype in response to signals from the environment. Based on new preliminary data indicating that ablation of commensal bacteria impairs lung host defense, we hypothesize that commensal bacteria induce IL-17-expressing lymphoid cells in the gut that is attenuated by CXCL5- induced influx of neutrophils. In the absence of full neutrophil availability, IL-17- producing cells initite a systemic process inducing granulopoiesis and increasing lung host defense. Using murine systems, we will address the following Specific Aims: 1. Determine whether granulocytic hyperplasia in CXCR2-/- and CXCL5-/- mice is due to activation of an IL-1/IL-23/IL-17/G-CSF pathway, addressing whether the source of IL-17 is at mucosal sites, and the role of innate lymphoid cells. 2. Determine whether the IL- 17/G-CSF axis mediates the enhanced lung host defense seen in CXCL5-/- mice, focusing on regulation of trafficking of IL-17 cells and neutrophils, and modification of lung host defense genes 3. Determine the importance of commensal bacteria in regulating host defense through IL-17. These studies will address critical unanswered questions in how alterations in gut microbes may alter the lung resistance to bacterial infection, and offer new routes to enhance host resistance or decrease neutrophilic inflammation in the lung.
描述(由申请人提供):趋化因子受体CXCR2是小鼠ELR+ CXC趋化因子的唯一受体,其缺失会增加骨髓中的中性粒细胞和祖细胞,以及G-CSF和IL-17A的全身表达。我们的CXCL5-/-小鼠缺乏一种CXCR2配体,表达一种中间表型,表明CXCL5通过CXCR2参与控制颗粒生成。此外,这些小鼠对严重肺炎的抵抗力更强。我们的数据表明,IL-17通过响应来自环境的信号来调节这种表型。基于新的初步数据表明,共生菌的消融会损害肺宿主防御,我们假设共生菌诱导肠道中表达il -17的淋巴细胞被CXCL5诱导的中性粒细胞内流减弱。在中性粒细胞缺乏的情况下,产生IL-17的细胞启动一个系统性过程,诱导粒细胞生成并增加肺宿主防御。使用小鼠系统,我们将解决以下具体目标:1。确定CXCR2-/-和CXCL5-/-小鼠的粒细胞增生是否由于IL-1/IL-23/IL-17/G-CSF通路的激活,确定IL-17的来源是否在粘膜部位,以及先天淋巴样细胞的作用。2. 确定IL-17 /G-CSF轴是否介导CXCL5-/-小鼠肺宿主防御增强,重点关注IL-17细胞和中性粒细胞运输的调节,以及肺宿主防御基因的修饰3。确定共生菌通过IL-17调节宿主防御的重要性。这些研究将解决肠道微生物改变如何改变肺部对细菌感染的抵抗力的关键问题,并提供增强宿主抵抗力或减少肺部中性粒细胞炎症的新途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

George SCOTT WORTHEN其他文献

George SCOTT WORTHEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('George SCOTT WORTHEN', 18)}}的其他基金

CXC Chemokines and Regulation of Granulopoiesis
CXC 趋化因子和粒细胞生成的调节
  • 批准号:
    8800537
  • 财政年份:
    2013
  • 资助金额:
    $ 39.36万
  • 项目类别:
CXC Chemokines and Regulation of Granulopoiesis
CXC趋化因子和粒细胞生成的调节
  • 批准号:
    8636398
  • 财政年份:
    2013
  • 资助金额:
    $ 39.36万
  • 项目类别:
Chemokine Compartmentalization and Neutrophil Accumulation in the Lung
肺部趋化因子区室化和中性粒细胞积聚
  • 批准号:
    8302274
  • 财政年份:
    2011
  • 资助金额:
    $ 39.36万
  • 项目类别:
Chemokine Compartmentalization and Neutrophil Accumulation in the Lung
肺部趋化因子区室化和中性粒细胞积聚
  • 批准号:
    8682900
  • 财政年份:
    2011
  • 资助金额:
    $ 39.36万
  • 项目类别:
Chemokine Compartmentalization and Neutrophil Accumulation in the Lung
肺部趋化因子区室化和中性粒细胞积聚
  • 批准号:
    8187532
  • 财政年份:
    2011
  • 资助金额:
    $ 39.36万
  • 项目类别:
Chemokine Compartmentalization and Neutrophil Accumulation in the Lung
肺部趋化因子区室化和中性粒细胞积聚
  • 批准号:
    8499406
  • 财政年份:
    2011
  • 资助金额:
    $ 39.36万
  • 项目类别:
Training Program in Genome-Environment Interactions in Neonatal Disease
新生儿疾病基因组-环境相互作用培训计划
  • 批准号:
    8477060
  • 财政年份:
    2010
  • 资助金额:
    $ 39.36万
  • 项目类别:
Training Program in Genome-Environment Interactions in Neonatal Disease
新生儿疾病基因组-环境相互作用培训计划
  • 批准号:
    8310970
  • 财政年份:
    2010
  • 资助金额:
    $ 39.36万
  • 项目类别:
Training Program in Genome-Environment Interactions in Neonatal Disease
新生儿疾病基因组-环境相互作用培训计划
  • 批准号:
    7869879
  • 财政年份:
    2010
  • 资助金额:
    $ 39.36万
  • 项目类别:
Training Program in Genome-Environment Interactions in Neonatal Disease
新生儿疾病基因组-环境相互作用培训计划
  • 批准号:
    8109409
  • 财政年份:
    2010
  • 资助金额:
    $ 39.36万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.36万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.36万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.36万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.36万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.36万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.36万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.36万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.36万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.36万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.36万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了